Skip to main content



Local Cdiff information for Texas

Texas

Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Texas.



Local Cdiff information for Texas

Texas

Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Texas.

Providers

Mike Bismar, MD, FACG

Texas Health Huguley Hospital
Medical Office Building 3
11801 South Freeway,
Suite 140
Burleson, Texas 76028

(817) 551-6161

VISIT WEBSITE>

Dr. Herbert L. DuPont, MD

Chief, Internal Medicine Service
St. Luke’s Medical Clinic
1200 Pressler, Suite E733
Houston, 77030
(713) 500-9366
EMAIL DR. DUPONT >
FMT Provider: Yes
VISIT WEBSITE >

Dr. John Manaloor, MD

Assistant Professor of Clinical Pediatrics
The Children’s Hospital of San Antonio
333 N Santa Rosa St
San Antonio, 78207
877-465-1856
FMT Provider: No
VISIT WEBSITE >

Regulation

C. diff Infections

Total Reported Cases: 5716
Hospital Onset: 5716
Community Onset: Not reported
Related Deaths: Not reported

Available Reports

Annual Progress based on SIR: 0.64
CDC STATE PROGRESS REPORT >
STATE REPORTING >

State Reporting Laws

Data Submission Required: No
Data Publicly Available: No
Data Validated: No
Facility-specific Data Publicly Reported: No
LTC Facility Submission Required: No
LTC Facility Data Publicly Reported: No
Law/Regulation: Not available
STATUTE >

State Contact

Shawn Tupy MT, MBA
Healthcare Safety Group Manager
Texas Department of State Health Services
Emerging and Acute Infectious Disease Branch
1100 W 49th Street
Austin, 78756
(512) 776-6355
EMAIL SHAWN TUPY MT, MBA >

CLINICAL TRIALS

FMT National Registry

Official Title: Fecal Microbiota Transplant National Registry
Trial No. NCT03325855
Type: Observational
Recruitment: Recruiting
Sponsor: American Gastroenterological Association
Contact: Sonya Serra, MSc
301-941-2616
EMAIL
Gender: All
Age: All ages

ROAR

Official Title: REBYOTA™ for the Prevention of Recurrence of Clostridioides Difficile Infection (CDI) in Adult Patients: An Observational Study
Trial No. NCT05835219
Type: Observational
Recruitment: Recruiting
Sponsor: Ferring Pharmaceuticals
Contact: Global Clinical Compliance
833-548-1402
EMAIL >
Gender: All
Age: 18 Years and older

RESTORATiVE303

Official Title: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Trial No. NCT06237452
Type: Interventional
Recruitment: Recruiting
Sponsor: Vedanta Biosciences, Inc
Contact: Mary Garfield
EMAIL >
Gender: All
Age: 12 Years and older
Vedanta Biosciences has teamed up with Science37 to provide a site-less, decentralized approach. This means the study can be done remotely and the product comes to you, in your home. This allows applicants who are not near a study site or unable to travel to participate and receive treatment. You can sign up for the decentralized study here.

DYNAMITE

Official Title: Dynamics of Colonization and Infection by Multidrug-Resistant Pathogens in Immunocompromised and Critically Ill Patients
Trial No. NCT06258551
Type: Observational
Recruitment: Recruiting
Sponsor: The Methodist Hospital Research Institute
Contact: Cesar A Arias, MD, PhD, Msc
EMAIL >
Gender: All
Age: 18 years and older

LMN-201

Official Title: A Phase 2, Randomized, Double-blind, Placebo-controlled Study of LMN-201 for Prevention of C. Difficile Infection Recurrence
Trial No. NCT05330182
Type: Interventional
Recruitment: Recruiting
Sponsor: Lumen Bioscience, Inc.
Contact: Carl Mason, MD
EMAIL >
Gender: All
Age: 18 years and older